Cell Culture and Tissue Engineering
Supermacroporous polymer-based cryogel bioreactor for monoclonal antibody production in continuous culture using hybridoma cells
Article first published online: 23 SEP 2010
DOI: 10.1002/btpr.497
Copyright © 2010 American Institute of Chemical Engineers (AIChE)
Additional Information
How to Cite
Jain, E., Karande, A. A. and Kumar, A. (2011), Supermacroporous polymer-based cryogel bioreactor for monoclonal antibody production in continuous culture using hybridoma cells. Biotechnol Progress, 27: 170–180. doi: 10.1002/btpr.497
Publication History
- Issue published online: 10 FEB 2011
- Article first published online: 23 SEP 2010
- Accepted manuscript online: 25 AUG 2010 09:26AM EST
- Manuscript Revised: 16 MAY 2010
- Manuscript Received: 27 FEB 2010
Funded by
- Indian Institute of Technology, Kanpur, India
- Department of Biotechnology (DBT) and Department of Science and Technology (DST), Ministry of Science and Technology, Govt. of India
- Abstract
- Article
- References
- Cited By
Keywords:
- antibody production;
- continuous culture;
- cryogel bioreactor;
- hybridoma cells;
- polymer scaffolds
Abstract
Cryogel matrices composed of different polymeric blends were synthesized, yielding a unique combination of hydrophilicity and hydrophobicity with the presence or absence of charged surface. Four such cryogel matrices composed of polyacrylamide–chitosan (PAAC), poly(N-isopropylacrylamide)–chitosan, polyacrylonitrile (PAN), and poly(N-isopropylacrylamide) were tested for growth of different hybridoma cell lines and production of antibody in static culture. All the matrices were capable for the adherence of hybridoma cell lines 6A4D7, B7B10, and H9E10 to the polymeric surfaces as well as for the efficient monoclonal antibody (mAb) production. PAAC proved to be relatively better in terms of both mAb production and cell growth. Further, PAAC cryogel was designed into three different formats, monolith, disks, and beads, and used as packing material for packed-bed bioreactor. Long-term cultivation of 6A4D7 cell line on PAAC cryogel scaffold in all the three formats could be successfully done for a period of 6 weeks under static conditions. Continuous packed-bed bioreactor was setup using 6A4D7 hybridoma cell line in the three reactor formats. The reactors ran continuously for a period of 60 days during which mAb production and metabolism of cells in the bioreactors were monitored periodically. The monolith bioreactor performed most efficiently over a period of 60 days and produced a total of 57.5 mg of antibody in the first 30 days (in 500 mL) with a highest concentration of 115 μg mL−1, which is fourfold higher than t-flask culture. The results demonstrate that appropriate chemistry and geometry of the bioreactor matrix for cell growth and immobilization can enhance the reactor productivity. © 2010 American Institute of Chemical Engineers Biotechnol. Prog., 2011

1520-6033/asset/BTPR_left.gif?v=1&s=a5be2ff5a0fe6ccdaad74a6d128c142e5f71a8da)
1520-6033/asset/BTPR_right.gif?v=1&s=992d113a3e61fc9d3571812359165df86cf830e4)
